Kristi Lyn Rhodes, OD | |
29605 N Cave Creek Rd Ste 102, Cave Creek, AZ 85331-2360 | |
(480) 781-4446 | |
Not Available |
Full Name | Kristi Lyn Rhodes |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 20 Years |
Location | 29605 N Cave Creek Rd Ste 102, Cave Creek, Arizona |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134120850 | NPI | - | NPPES |
685453 | Medicaid | AZ | |
86-0884211 | Other | TAX ID |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
K Rhodes Od Pllc | 8527435171 | 2 |
News Archive
A team of researchers from Spain and Switzerland have developed a new model for studying the development of testicular germ cell tumors by transplanting embryonic stem cells into the seminiferous tubules in mouse models, resulting in the development of testicular germ cell tumors (TGCT) that mimic the early stages of TGCT development.
The Food and Drug Administration (FDA) in the U.S. has alerted the public that a brand of blood glucose test strips used by people with diabetes to measure their blood glucose, are counterfeit.
By applying a systems biology approach, a recent bioRxiv* preprint research paper by scientists from the Icahn School of Medicine at Mount Sinai in New York unveils interactions between the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and p38 mitogen-activated protein kinase (MAPK) pathway responsible for regulating the expression of crucial inflammatory mediators in human lung epithelial cells.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
› Verified 5 days ago
Provider Name | Jay L Schwartz Do Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1366497711 PECOS PAC ID: 0143285841 Enrollment ID: O20041122000972 |
News Archive
A team of researchers from Spain and Switzerland have developed a new model for studying the development of testicular germ cell tumors by transplanting embryonic stem cells into the seminiferous tubules in mouse models, resulting in the development of testicular germ cell tumors (TGCT) that mimic the early stages of TGCT development.
The Food and Drug Administration (FDA) in the U.S. has alerted the public that a brand of blood glucose test strips used by people with diabetes to measure their blood glucose, are counterfeit.
By applying a systems biology approach, a recent bioRxiv* preprint research paper by scientists from the Icahn School of Medicine at Mount Sinai in New York unveils interactions between the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and p38 mitogen-activated protein kinase (MAPK) pathway responsible for regulating the expression of crucial inflammatory mediators in human lung epithelial cells.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
› Verified 5 days ago
Provider Name | K Rhodes Od Pllc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1861118408 PECOS PAC ID: 8527435171 Enrollment ID: O20221110001772 |
News Archive
A team of researchers from Spain and Switzerland have developed a new model for studying the development of testicular germ cell tumors by transplanting embryonic stem cells into the seminiferous tubules in mouse models, resulting in the development of testicular germ cell tumors (TGCT) that mimic the early stages of TGCT development.
The Food and Drug Administration (FDA) in the U.S. has alerted the public that a brand of blood glucose test strips used by people with diabetes to measure their blood glucose, are counterfeit.
By applying a systems biology approach, a recent bioRxiv* preprint research paper by scientists from the Icahn School of Medicine at Mount Sinai in New York unveils interactions between the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and p38 mitogen-activated protein kinase (MAPK) pathway responsible for regulating the expression of crucial inflammatory mediators in human lung epithelial cells.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Kristi Lyn Rhodes, OD Po Box 72802, Phoenix, AZ 85050-1031 Ph: (541) 390-9667 | Kristi Lyn Rhodes, OD 29605 N Cave Creek Rd Ste 102, Cave Creek, AZ 85331-2360 Ph: (480) 781-4446 |
News Archive
A team of researchers from Spain and Switzerland have developed a new model for studying the development of testicular germ cell tumors by transplanting embryonic stem cells into the seminiferous tubules in mouse models, resulting in the development of testicular germ cell tumors (TGCT) that mimic the early stages of TGCT development.
The Food and Drug Administration (FDA) in the U.S. has alerted the public that a brand of blood glucose test strips used by people with diabetes to measure their blood glucose, are counterfeit.
By applying a systems biology approach, a recent bioRxiv* preprint research paper by scientists from the Icahn School of Medicine at Mount Sinai in New York unveils interactions between the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) and p38 mitogen-activated protein kinase (MAPK) pathway responsible for regulating the expression of crucial inflammatory mediators in human lung epithelial cells.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
› Verified 5 days ago
Eye Care North Optometrist Medicare: Medicare Enrolled Practice Location: 29605 N Cave Creek Rd Ste 102, Cave Creek, AZ 85331 Phone: 480-241-7620 | |
K Rhodes Od Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 29605 N Cave Creek Rd Ste 102, Cave Creek, AZ 85331 Phone: 541-390-9667 | |
Dr. Julie Lam, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 29605 N Cave Creek Rd Ste 102, Cave Creek, AZ 85331 Phone: 480-361-7040 Fax: 480-361-5223 |